Costco to stop selling abortion pill mifepristone at its US pharmacy stores

Costco Wholesale announced it will cease selling the abortion pill mifepristone across all its U.S. pharmacies, citing low demand. This decision follows pressure from religious activist groups, highlighting a broader trend where retailers are becoming more cautious about taking social or political stances to avoid consumer backlash and boycotts. Activist groups are now expected to focus their efforts on Walgreens and CVS Health, which continue to dispense the medication in states where it is legally permissible.

Analysis

Costco Wholesale is ceasing the sale of mifepristone across its more than 500 U.S. pharmacies, citing a lack of demand as the primary driver for a decision it states is not a change in its position. This corporate action occurs within a broader context of pressure from religious activist groups targeting major retailers. According to a CFRA senior analyst, this move exemplifies a growing trend of retailers exercising caution to avoid taking overt political or social stances that could trigger boycotts and negative media attention. Consequently, activist campaigns are now expected to shift their focus towards competitors like Walgreens and CVS Health, both of which have stated they will continue to dispense the medication in states where it is legally permissible. Other retailers are showing varied responses, with Kroger reviewing the FDA's updated drug safety program and Walmart declining to comment, highlighting a strategic divergence in managing reputational and political risk within the retail pharmacy sector.

Key Decisions for Investors

• Investors should view Costco's decision as a defensive move to mitigate reputational risk and avoid politically charged consumer boycotts, a factor that likely outweighs the negligible revenue impact from the low-demand product.
• For those holding positions in Walgreens and CVS, it is critical to monitor for heightened activist pressure and potential headline risk, as these companies now become the central focus for campaigns related to mifepristone distribution.
• The diverging approaches among major pharmacy retailers like Costco, CVS, and Kroger underscore a key operational risk factor in the sector, where navigating social and political issues is becoming integral to brand management and customer retention.